This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Letters to the Editor

Apparent Commercial Bias in Supplement

Daniel Carlat, MD

Published: June 30, 2008

Article Abstract

Letter to the Editor

Sir: I read your recent supplement " Translating the Psychopharmacology of Antipsychotics to Individualized Treatment for Severe Mental Illness: A Roadmap" with interest.

As a practicing psychiatrist with experience prescribing the full range of antipsychotics, I recognize the need for detailed information to help clinicians decide among the many choices in our armamentarium. While the supplement was published to address this need, I have serious questions regarding its scientific integrity.


Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Related Articles

Volume: 69

Quick Links: Journal

References

Sign-up to stay
up-to-date today!

SUBSCRIBE

Already registered? Sign In

Case Report

Safety and Tolerability of Concomitant Intranasal Esketamine Treatment With Irreversible, Nonselective MAOIs: A Case Series

Three cases suggest that concomitant use of intranasal esketamine with an irreversible, nonselective MAOI is safe in...

Read More...